Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry

Canadian Journal of Cardiology(2023)10.1016/j.cjca.2023.06.001Source: DataRank Database

Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry is a research paper published in Canadian Journal of Cardiology (2023). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 5.91)OA: bronzeTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (72)

Samay Shah,Frédéric Dallaire ORCID,Cedric Manlhiot ORCID,Michael Khoury ORCID,Simon Lee ORCID

Live enrichment

PubMed:37290536 PMC:PMC10245460 OpenAlex:https://openalex.org/W4379618779

NICHD NIH HHS

Grant: R33 HD105591

NICHD NIH HHS

Grant: R61 HD105591

National Institutes of Health

Grant: 1R61HD105591-01

A data science approach to identify and manage Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 infection and Kawasaki disease in pediatric patients

FWCI

5.91

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: Elsevier TDM

journalhttp://onlinecjc.ca/article/S0828282X23004518/pdf

publisherhttp://onlinecjc.ca/article/S0828282X23004518/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0828282X23004518?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0828282X23004518?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cjca.2023.06.001

Fields of Study

Kawasaki Disease and Coronary ComplicationsLymphadenopathy Diagnosis and AnalysisCoronary Artery AnomaliesRegistriesChildCOVID-19HumansSystemic Inflammatory Response SyndromeMucocutaneous Lymph Node SyndromeSARS-CoV-2pediatric multisystem inflammatory disease, COVID-19 related

MeSH Terms

COVID-19SARS-CoV-2ChildHumansMucocutaneous Lymph Node SyndromeRegistriesSystemic Inflammatory Response Syndrome

Keywords

Kawasaki diseaseMedicineCoronavirus disease 2019 (COVID-19)PandemicDisease2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PediatricsInternal medicineVirologyInfectious disease (medical specialty)OutbreakSARS-CoV-2COVID-19HumansRegistriesMucocutaneous Lymph Node SyndromeChildSARS-CoV-2 infection; multisystem inflammatory syndrome in children; Kawasaki diseaseSystemic Inflammatory Response Syndrome

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being